The journal retracts the article, “Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma” [1].
During a recent investigation, the Albany College of Pharmacy and Health Sciences determined that multiple images were falsified or fabricated in this paper [1]. The misconduct findings are associated with the manipulation, re-use, and relabeling of images, and since the authors are members of Albany College, the college has requested the retraction of the article.
A correction [1] was submitted. However, the authors did not sufficiently explain the issues with the original images to the investigation committee, creating cause for concern regarding the validity of the experiments.
This retraction was approved by the Editor-in-Chief of the journal Cancers.
The authors did not agree with this retraction.
Reference
- Godugu, K.; Rajabi, M.; Mousa, S.A. RETRACTED: Anti-Cancer Activities of Thyrointegrin αvβ3 Antagonist Mono- and Bis-Triazole Tetraiodothyroacetic Acid Conjugated via Polyethylene Glycols in Glioblastoma. Cancers 2021, 13, 2780, corrected in Cancers 2022, 14, 5371. https://doi.org/10.3390/cancers14215371. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).